Application of Antiosteoporosis Therapy in Osteolysis

Henan Cancer Hospital

Status: Not yet enrolling

Conditions: Limb; Fusion; Complication

Treatments: Other: Anti-osteoporosis therapy

Study type: Observational

Funder types: Other

Identifiers

NCT05617846

ZZUSC-19

Details and patient eligibility

About

To report the postoperative complications and limb function of patients with osteolysis after surgery for bone tumors of the extremities who received anti-osteoporosis therapy in Henan Cancer Hospital in the next 10 years.

Full description

A total of 100 patients with osteolysis after surgery for bone tumors of the four extremities who received anti-osteoporosis treatment in Henan Cancer Hospital in the next 10 years were reported. The basic information, treatment methods, postoperative complications and limb function of these patients were collected.

Enrollment: 100 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

1. No age restriction, male or female.
2. A subtype of bone tumor (including benign, malignant, and metastatic cancer) was confirmed in the pathology department of the research institution.
3. Received excision of bone tumor in research institution.

Exclusion criteria

Not applicable.

Trial design

100 participants in 2 patient groups

Intervention group

Description:

Patients who received antiosteoporosis therapy after bone tumor resection

Treatment:

Other: Anti-osteoporosis therapy

Control group

Description:

Patients who underwent bone tumor resection without antiosteoporosis therapy